Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
BACK TO LIST

European Patient Summary

Patient
Name: Knudsen, Albert
DOB: 25-JAN-1978 (Age: 47)
Gender: male
ID: 8668-391327-0 (ECI)
Author
Dr. Ping, Hel
Patient summary Document
European Patient Summary
Report Date: 27-NOV-2024

Problem list

Condition Onset Date Status
Essential hypertension 18-Oct-2017 active
Dependent drug abuse 21-Mar-1998 active

Medication list

No known medications

Immunizations list

Vaccine Date
Clostridium tetani toxoid antigen adsorbed only vaccine product 27-Nov-2024
Live attenuated Human alphaherpesvirus 3 only vaccine product 27-Nov-2024
Influenza virus antigen only vaccine product 27-Nov-2024
COVID-19 non-replicating viral vector vaccine 21-Apr-2021
Hepatitis A virus antigen only vaccine product 14-Oct-2015

Procedure History list

Procedure Date Reason
Depression screening 14-Dec-2022 -
Assessment of health and social care needs 14-Dec-2022 -
Assessment of anxiety 14-Dec-2022 -
Depression screening using Patient Health Questionnaire Two-Item score (procedure) 14-Dec-2022 -
Plain X-ray of clavicle 01-Dec-2019 -
Admission to orthopedic department 01-Dec-2019 Fracture of clavicle

Allergies and Intolerances

Allergy/Intolerance Onset Date Status Type Reaction
? active ?

Care Plan

Active Planned Care / Goals Start Date Reason
Lifestyle education regarding hypertension 18-Oct-2017 Essential hypertension (disorder)
  • Patient will achieve and maintain blood pressure below 130/80 mmHg through lifestyle changes including diet, exercise, and sodium reduction.
Care plan 08-Nov-2000 -

Vital Signs

Vital Signs 2024-11-27 2023-11-22
Body Height 174.3 cm 174.3 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported 1 {score} 0 {score}
Body Weight 91.6 kg 89.8 kg
Body mass index (BMI) [Ratio] 30.1 kg/m2 29.6 kg/m2
Diastolic Blood Pressure 92 mm[Hg] 95 mm[Hg]
Systolic Blood Pressure 136 mm[Hg] 134 mm[Hg]
Heart rate 83 /min 72 /min
Respiratory rate 12 /min 13 /min

Relevant diagnostic tests/laboratory data

Recent Lab Observations 27-NOV-2024 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 296.9 H 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 122.9 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 214.8 H 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 57.5 40 - 60 mg/dL